NANOTRANS TECHNOLOGIES, INC.

Basic Information

14 E 96TH ST
NEW YORK, NY, 10128-0781

Company Profile

n/a

Additional Details

Field Value
DUNS: 829871495
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Topical Nanoparticles for CNV

    Amount: $271,468.00

    DESCRIPTION (provided by applicant): Age Related Macular Degeneration (AMD) is the leading cause of blindness in adults over 50 years. Choroidal neovascularization (CNV), the pathologic creation of ne ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government